$AEHR Income Statement | Understand Stock

$AEHR

$56.60 +$1.29 (2.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to May 29, 2026	FY2025 12 months to May 30, 2025	FY2024 12 months to May 31, 2024	FY2023 12 months to May 31, 2023	FY2022 12 months to May 31, 2022
Revenue
Product
Service
Total revenue
Cost of revenue
Product
Service
Total cost of revenue
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Restructuring charges
Total operating expenses
Income (loss) from operations
Interest income, net
Net gain due to cumulative translation adjustment reclassiefied to earnings
Net gain from dissolution of Aehr Test Systems Japan
Other income (expense), net
Gain from forgiveness of PPP loan
Income (loss) before income tax benefit
Income tax benefit
Net income (loss)

Net income (loss)
Net income (loss) per share:
Basic net income (loss) per share
Diluted net income (loss) per share
Shares used in per share calculation - basic
Basic
Diluted

Comments